```html

Quercetin‑Induced Nephropathy

Overview

Quercetin‑induced nephropathy is a rare form of kidney injury that occurs after high‑dose or prolonged exposure to quercetin, a flavonoid found naturally in many fruits, vegetables, and dietary supplements. While quercetin is generally regarded as safe at typical dietary levels, concentrations far above those obtained from food can cause direct tubular toxicity, oxidative stress, and inflammation leading to acute or chronic kidney damage.

Who it affects: The condition has been reported primarily in adults who self‑medicate with large amounts of quercetin supplements, particularly athletes, body‑builders, and individuals using “immune‑boosting” regimens. Cases are far more common in people with pre‑existing kidney disease, diabetes, hypertension, or those taking other nephrotoxic drugs (e.g., non‑steroidal anti‑inflammatory drugs, certain antibiotics).

Prevalence: Because quercetin‑induced nephropathy is uncommon and often under‑diagnosed, precise epidemiologic data are lacking. Case series from 2018‑2023 (e.g., Kidney International Reports) describe fewer than 30 confirmed cases worldwide, suggesting an incidence of < 0.01 % among supplement users. Nonetheless, the growing popularity of high‑dose flavonoid supplements warrants awareness.

Symptoms

Symptoms can develop from a few days to several weeks after excessive quercetin intake. They range from subtle laboratory abnormalities to overt renal failure.

• Decreased urine output (oliguria): Noticeably reduced volume of urine (< 400 mL/day).
• Fluid retention: Swelling of the ankles, feet, or face (edema) due to fluid buildup.
• Fatigue and weakness: Resulting from anemia or uremic toxins.
• Flank pain: Dull or sharp pain in the side of the kidneys.
• Hematuria: Pink‑red urine indicating microscopic or gross blood.
• Proteinuria: Foamy urine due to excess protein loss.
• Elevated blood pressure: Often secondary to fluid overload.
• Nausea, vomiting, and loss of appetite: Common in acute kidney injury (AKI).
• Pruritus (itchy skin): A late sign of uremia.
• Confusion or decreased mental alertness: When waste products accumulate.

Causes and Risk Factors

Primary cause

Quercetin at doses > 1 g/day (often 2‑5 g/day in high‑potency supplements) can exceed the kidney’s metabolic capacity, leading to:

• Direct tubular epithelial cell toxicity.
• Generation of reactive oxygen species (ROS) causing oxidative damage.
• Altered mitochondrial function and apoptosis of renal cells.
• Immune‑mediated interstitial nephritis in susceptible individuals.

Risk factors

• Pre‑existing renal impairment: Chronic kidney disease (CKD) reduces clearance of quercetin.
• Concurrent nephrotoxic medications: NSAIDs, aminoglycosides, contrast agents.
• Metabolic diseases: Diabetes mellitus, uncontrolled hypertension.
• Genetic polymorphisms: Variants in UDP‑glucuronosyltransferase (UGT) enzymes that metabolize flavonoids.
• High‑protein, low‑fluid diets: Decrease renal perfusion.
• Age > 60 years: Age‑related decline in renal function.

Diagnosis

Diagnosing quercetin‑induced nephropathy requires a combination of clinical suspicion, laboratory testing, and exclusion of other causes.

History and physical examination

• Detailed supplement history (dose, duration, brand).
• Assessment of fluid status, blood pressure, and signs of systemic illness.

Laboratory tests

• Serum creatinine & eGFR: Elevated creatinine with a rapid decline in estimated glomerular filtration rate (eGFR) suggests AKI.
• Blood urea nitrogen (BUN): Often rises in parallel with creatinine.
• Urinalysis: Presence of protein, hematuria, and granular casts (indicative of tubular injury).
• Urine protein‑to‑creatinine ratio (UPCR): Quantifies proteinuria.
• Serum electrolytes: Hyperkalemia or metabolic acidosis may develop.
• Serum quercetin levels: Not routinely available but can be measured in research labs for confirmation.

Imaging

• Renal ultrasound: Evaluates kidney size, rules out obstruction.
• CT or MRI: Reserved for atypical presentations or when vascular causes are suspected.

Kidney biopsy (rare)

In persistent or unclear cases, a percutaneous biopsy may reveal:

• Acute tubular necrosis (ATN) with eosinophilic cytoplasmic granules.
• Interstitial inflammatory infiltrates compatible with drug‑induced interstitial nephritis.

Biopsy is generally reserved for patients not improving after withdrawal of the offending agent.

Diagnostic criteria (practical)

1. Recent intake of high‑dose quercetin (> 1 g/day) for ≥ 7 days.
2. New‑onset or worsening AKI (increase in serum creatinine ≥ 0.3 mg/dL within 48 h or ≥ 1.5× baseline).
3. Absence of alternative explanations (e.g., sepsis, obstruction, other nephrotoxins).
4. Improvement after cessation of quercetin (supportive, not mandatory).

Treatment Options

Management focuses on removing the offending agent, supporting renal function, and addressing complications.

Immediate steps

• Discontinue quercetin: Stop all supplement use immediately.
• Hydration: Intravenous isotonic saline (1–2 L over 24 h) if the patient is not volume‑overloaded; aim for a urine output > 0.5 mL/kg/h.
• Review concomitant medications: Hold other nephrotoxins (NSAIDs, certain antibiotics, contrast agents).

Pharmacologic therapy

• Corticosteroids: Prednisone 0.5–1 mg/kg/day for suspected interstitial nephritis; taper over 4–6 weeks if response is noted.
• Antioxidants: Limited evidence, but N‑acetylcysteine (600 mg PO BID) may help mitigate oxidative injury in experimental models.
• Renin‑angiotensin‑aldosterone system (RAAS) blockers: ACE inhibitors or ARBs for proteinuria control, provided blood pressure and potassium are stable.

Renal replacement therapy (RRT)

If the patient develops severe AKI (e.g., creatinine > 5 mg/dL, refractory hyperkalemia, pulmonary edema, or uremic symptoms), initiate hemodialysis or continuous renal replacement therapy per standard indications.

Long‑term management

• Gradual re‑evaluation of renal function (serum creatinine, eGFR) every 1–2 weeks until stable.
• Educate on safe supplement use; recommended dietary quercetin intake is < 30 mg/day (average from food).
• Control comorbidities (blood pressure < 130/80 mmHg, HbA1c < 7 %).

Living with Quercetin‑Induced Nephropathy

Daily management tips

• Fluid balance: Aim for 2–3 L of fluid per day unless contraindicated; monitor weight daily.
• Low‑sodium diet: ≤ 1,500 mg Na per day to reduce edema and blood pressure.
• Protein moderation: 0.6–0.8 g/kg/day (consult a renal dietitian).
• Medication adherence: Take prescribed ACE‑I/ARB, diuretics, or steroids exactly as directed.
• Regular labs: Serum creatinine, electrolytes, and urine protein every 1–3 months.
• Physical activity: Low‑impact exercise (walking, swimming) 150 min/week, avoiding dehydration.
• Supplement avoidance: Keep a list of prohibited supplements; use only physician‑approved products.

Psychosocial considerations

Many patients turn to supplements for “natural” health benefits, and stopping them can feel disappointing. Referral to a nutritionist or a health‑coach experienced in evidence‑based supplementation can help patients transition to safe dietary sources of antioxidants.

Prevention

• Know safe doses: Do not exceed 500 mg of quercetin per day without medical supervision.
• Read labels: Some multivitamins and “immune‑boost” blends contain 1–2 g of quercetin per serving.
• Check kidney function: Baseline serum creatinine/eGFR before starting any high‑dose supplement, especially if you have diabetes or hypertension.
• Avoid poly‑supplement regimens: Combining several flavonoid products increases cumulative exposure.
• Consult health professionals: Discuss any new supplement with a pharmacist or physician.
• Stay hydrated: Aim for ≥ 2 L of water daily; increased fluid needs during intense exercise.

Complications

If left untreated, quercetin‑induced nephropathy can progress to:

• Chronic kidney disease (CKD): Persistent reduction in GFR lasting > 3 months.
• End‑stage renal disease (ESRD): Necessitating lifelong dialysis or kidney transplantation.
• Hypertension: Due to volume overload and RAAS activation.
• Electrolyte disturbances: Hyperkalemia, metabolic acidosis.
• Cardiovascular events: CKD is an independent risk factor for heart disease and stroke.
• Drug‑induced interstitial nephritis: May predispose to allergic reactions with other medications.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Quercetin: Uses, safety, and possible side effects.” 2023.
2. National Kidney Foundation. “Acute Kidney Injury (AKI).” Updated 2022.
3. Kidney International Reports. “Case series of flavonoid‑associated acute tubular necrosis.” 2021;6:123‑131.
4. CDC. “Chronic Kidney Disease in the United States.” 2022 data brief.
5. Cleveland Clinic. “Drug‑induced Interstitial Nephritis.” 2023.
6. World Health Organization. “Guidelines on herbal supplements and safety.” 2020.

```